These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 19801534)

  • 61. (Pre)diabetes, brain aging, and cognition.
    S Roriz-Filho J; Sá-Roriz TM; Rosset I; Camozzato AL; Santos AC; Chaves ML; Moriguti JC; Roriz-Cruz M
    Biochim Biophys Acta; 2009 May; 1792(5):432-43. PubMed ID: 19135149
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The Influence of Adipose Tissue on Brain Development, Cognition, and Risk of Neurodegenerative Disorders.
    Letra L; Santana I
    Adv Neurobiol; 2017; 19():151-161. PubMed ID: 28933064
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The therapeutic potential of metabolic hormones in the treatment of age-related cognitive decline and Alzheimer's disease.
    Grizzanti J; Lee HG; Camins A; Pallas M; Casadesus G
    Nutr Res; 2016 Dec; 36(12):1305-1315. PubMed ID: 27923524
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Cognitive impairment and cardiovascular disease risk factors. Project CASCADE Kraków. I. Project to test exposure to risk factors for cardiovascular disease in the studied sample].
    Pajak A; Kawalec E; Szczudlik A
    Przegl Lek; 1998; 55(12):676-82. PubMed ID: 10354721
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Obesity, leptin, and Alzheimer's disease.
    Lee EB
    Ann N Y Acad Sci; 2011 Dec; 1243():15-29. PubMed ID: 22211890
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cardiovascular and other risk factors for Alzheimer's disease and vascular dementia.
    Meyer JS; Rauch GM; Rauch RA; Haque A; Crawford K
    Ann N Y Acad Sci; 2000 Apr; 903():411-23. PubMed ID: 10818532
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The balance between cognitive reserve and brain imaging biomarkers of cerebrovascular and Alzheimer's diseases.
    Murray AD; Staff RT; McNeil CJ; Salarirad S; Ahearn TS; Mustafa N; Whalley LJ
    Brain; 2011 Dec; 134(Pt 12):3687-96. PubMed ID: 22102649
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cardiovascular risk factors and cognitive decline in middle-aged adults.
    Knopman D; Boland LL; Mosley T; Howard G; Liao D; Szklo M; McGovern P; Folsom AR;
    Neurology; 2001 Jan; 56(1):42-8. PubMed ID: 11148234
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Neuropsychological impairment in the early Alzheimer's disease].
    Traykov L; Rigaud AS; Cesaro P; Boller F
    Encephale; 2007; 33(3 Pt 1):310-6. PubMed ID: 17675928
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Association between mid-life marital status and cognitive function in later life: population based cohort study.
    Håkansson K; Rovio S; Helkala EL; Vilska AR; Winblad B; Soininen H; Nissinen A; Mohammed AH; Kivipelto M
    BMJ; 2009 Jul; 339():b2462. PubMed ID: 19574312
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Body weight status and onset of cognitive impairment among U.S. middle-aged and older adults.
    Xiang X; An R
    Arch Gerontol Geriatr; 2015; 60(3):394-400. PubMed ID: 25747849
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Susceptibility to diet-induced obesity and glucose intolerance in the APP (SWE)/PSEN1 (A246E) mouse model of Alzheimer's disease is associated with increased brain levels of protein tyrosine phosphatase 1B (PTP1B) and retinol-binding protein 4 (RBP4), and basal phosphorylation of S6 ribosomal protein.
    Mody N; Agouni A; McIlroy GD; Platt B; Delibegovic M
    Diabetologia; 2011 Aug; 54(8):2143-51. PubMed ID: 21538175
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Perforant path synaptic loss correlates with cognitive impairment and Alzheimer's disease in the oldest-old.
    Robinson JL; Molina-Porcel L; Corrada MM; Raible K; Lee EB; Lee VM; Kawas CH; Trojanowski JQ
    Brain; 2014 Sep; 137(Pt 9):2578-87. PubMed ID: 25012223
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Vascular disease and risk factors, rate of progression, and survival in Alzheimer's disease.
    Bhargava D; Weiner MF; Hynan LS; Diaz-Arrastia R; Lipton AM
    J Geriatr Psychiatry Neurol; 2006 Jun; 19(2):78-82. PubMed ID: 16690992
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Global Cardiovascular Risk Profile and Cerebrovascular Abnormalities in Presymptomatic Individuals with CADASIL or Autosomal Dominant Alzheimer's Disease.
    Schoemaker D; Velilla-Jimenez L; Zuluaga Y; Baena A; Ospina C; Bocanegra Y; Alvarez S; Ochoa-Escudero M; Guzmán-Vélez E; Martinez J; Lopera F; Arboleda-Velasquez JF; Quiroz YT
    J Alzheimers Dis; 2021; 82(2):841-853. PubMed ID: 34092645
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The Cache County Study on Memory in Aging: factors affecting risk of Alzheimer's disease and its progression after onset.
    Tschanz JT; Norton MC; Zandi PP; Lyketsos CG
    Int Rev Psychiatry; 2013 Dec; 25(6):673-85. PubMed ID: 24423221
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The epidemiology of the dementias: an update.
    Qiu C; De Ronchi D; Fratiglioni L
    Curr Opin Psychiatry; 2007 Jul; 20(4):380-5. PubMed ID: 17551353
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Variability in body weight precedes diagnosis in dementia: A nationwide cohort study.
    Ha J; Kwon Y; Kwon YJ; Kim D; Han K; Jang M; Park S; Nam GE; Kim YH; Kim DH; Park YG; Cho KH
    Brain Behav; 2020 Nov; 10(11):e01811. PubMed ID: 32856784
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Alzheimer's Disease and Exercise: A Literature Review.
    Cass SP
    Curr Sports Med Rep; 2017; 16(1):19-22. PubMed ID: 28067736
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.